Forty-nine (5%) of 956 women referred for follow-up imaging after brea
st cancer treatment had a malignancy in both breasts. The mammograms a
nd ultrasonograms or US reports, and histologic slides or pathologic r
eports of 31 of these patients were reviewed. Mammography was more sen
sitive than clinical examination or US in detecting contralateral brea
st cancer, the sensitivity of mammography being 81%. Thirty-nine perce
nt of the contralateral cancers were nonpalpable, and all were first d
etected at mammography. No cancers were depicted by US alone. US provi
ded complementary information about palpable masses in 50% of the case
s in which the mammographic finding was difficult to interpret. The ma
mmographic appearance and the difficulties in detecting a contralatera
l cancer were similar to those known to be characteristic for first pr
imaries. Distinguishing a new primary from a metastasis from the first
breast cancer was not always possible by means of mammography or US.